Compare Smith & Nephew plc (SNN) vs Western Union Co (WU) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Smith & Nephew plc vs Western Union Co — how do they compare? Smith & Nephew plc trades at $27.21 (market cap $11.31B), while Western Union Co trades at $6.32 (market cap $1.91B). The key difference: Smith & Nephew plc is far larger — about 5.9× Western Union Co's market cap, and Western Union Co pays the higher dividend (15.38%). Which is the better fit depends on your goals — on Pluang, investors hold Smith & Nephew plc for 120 Days and Western Union Co for 95 Days on average.
| SNN | WU | |
|---|---|---|
Market Cap | $11.31B | $1.91B |
Volume | 1,050,005 | 6,459,194 |
Sector | Health | Financials |
52-Week High | $37.17 | $10.28 |
52-Week Low | $26.42 | $5.90 |
Typical Hold Time | 120 Days | 95 Days |
Enterprise Value | $14.35B | $1.81B |
Dividend Yield | 2.95% | 15.38% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Smith & Nephew (SNN) trades at $26.89, near its 52-week low, with a bearish technical signal. Revenue grew to $6.16B in 2025, with net income margin improving to 10.08%. Recent product launches, like the EVOS PELVIC System, aim to strengthen its medical technology portfolio, though the stock faces headwinds from analyst downgrades and CFO departure news.
The outlook is cautious; while fundamentals show profitability growth, the stock's proximity to lows and mixed analyst sentiment (26% buy, 65% hold) suggest limited near-term upside. Key risks include competitive pressures and execution challenges, but the stable dividend and institutional interest offer some support for patient investors.
Western Union (WU) trades at $6.11, down 0.49% on the day, with bearish technical signals and mixed earnings performance. The stock shows attractive valuation metrics with a P/E of 4.93 and P/S of 0.48, while maintaining strong profitability with 9.79% net margins. Recent developments include the pending Intermex acquisition and expansion of retail partnerships, though earnings misses in Q1 and Q2 2026 raise execution concerns. Cash flow trends show volatility with a $469M net outflow in 2025.
WU presents a value opportunity with deep valuation discounts but faces execution risks amid digital transformation. The $200M cost-cutting plan and Intermex acquisition offer potential upside if successfully implemented, while competitive pressures and integration challenges pose downside risks. Analyst consensus at $6.86 suggests modest upside from current levels, though the mixed rating distribution reflects uncertainty about the turnaround strategy.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Smith & Nephew plc
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 42% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 28% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
Read more on SNN →About Western Union Co
Western Union provides domestic and international money transfers through its global network of about 500,000 outside agents. It is the largest money transfer company in the world and one of only a few companies with a truly global agent network.
Read more on WU →
